PARP1 and telomere syndrome: Therefore, based on the possibility that DDR molecules might be therapeutic targets of STS, this study examined the immunohistochemical expression of the DDR molecules PARP1, γH2AX, BRCA1, and BRCA2 in STSs, and evaluated the prognostic significance of their expression in STSs.